Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial
Mehdi Kardoost Parizi
Mehdi Kardoost Parizi

Associate Professor of Urology

Department Urology

School of Medicine

Shariati Hospital

Tehran University of Medical Sciences

All Documents
26. Metastasis-Directed Therapy: New Standard or Too Early to Change Paradigm?, Memo - Magazine of European Medical Oncology (2024)
36. Reservation of Male Fertility in Patients Undergoing Pelvic Irradiation, Reports of Practical Oncology and Radiotherapy (2023)